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intact rim was directly proportional to the increasing size of the Amplatzer (range 0.05 to
1.5 lbs). In the samples with segments of atrial rim excised, the force required was signif-
icantly less (range 0.2 to 0.85 lbs, p<0.02). Loss of 30% of the atrial rim segment pro-
duced a 40% mean reduction (p<0.05) in the amount of force required to dislodge the
device.
Conclusion: There is a linear relationship between the size of the Amplatzer device and
force needed to pull it through an ASD. The circumference of atrial rim is important in
securing the device. The ASD area plus excised rim area to Amplatzer area ratio of >0.6
causes a marked reduction in the stability of this device.
1019-204 Doppler Tissue Imaging Analysis of Ventricular 
Function After Surgical and Transcatheter Closure of 
Atrial Septal Defect
Yiu-Fai Cheung, Kin-shing Lun, Adolphus K. Chau, The University of Hong Kong, Hong 
Kong, Hong Kong
Background - The long-term ventricular function after surgical and transcatheter closure
of ASD is uncertain. We assessed the right ventricular (RV) and left ventricular (LV) func-
tion of children after surgical and transcatheter closure of atrial septal defect (ASD) using
Doppler tissue imaging (DTI), and compared to that of age-matched healthy controls.
Methods - Two-dimensional M-mode echocardiography, transmitral Doppler assessment
and pulsed DTI were performed in 17 patients at 5.4±3.0 years after surgical closure of
ASD (group I), 17 patients at 3.5±0.9 years after transcatheter closure by Amplatzer sep-
tal occluder (group II) and 17 healthy control subjects (group III). The RV and LV myocar-
dial performance was assessed by the DTI-derived Tei index. Results - The M-mode
measurements, transmitral Doppler indexes and LV Tei indexes did not differ among
groups. In group I, the tricuspid annular systolic and diastolic velocities and basal inter-
ventricular septum (IVS) systolic velocity were significantly lower than those of group II
and III (p<0.05). Furthermore, these patients had impairment of RV myocardial perfor-
mance as reflected by the significantly greater RV Tei index (I vs II vs III, 0.52±0.11 vs
0.40±0.10 vs 0.40±0.09, p=0.003), being related primarily to prolongation of isovolumic
contraction time (p=0.001). The RV Tei index correlated negatively with tricuspid annular
systolic velocity (r=-0.44, p=0.001) and basal IVS systolic velocity (r=-0.31, p=0.026).
Group II patients, on the other hand, had pulsed DTI indexes and myocardial perfor-
mance similar to those of normal controls. Conclusion - Surgical repair of ASD is associ-
ated with abnormal RV long-axis function and myocardial performance in the long-term.
Transcatheter device closure, on the other hand, preserves ventricular function and
should therefore be the treatment of choice for anatomically suitable defects.
1019-205 Do Patients of Advanced Age Benefit From 
Transcatheter Atrial Septal Defect Closure?
Raphael Rosenhek, Harald Gabriel, Florian Rader, Maria Heger, Thomas Binder, Gerald 
Maurer, Peter Probst, Helmut baumgartner, University of Vienna, Vienna, Austria
Background: Transcatheter atrial septal defect (ASD) closure has been shown to be fea-
sible and safe in children as well as adults. However, little is known about the clinical ben-
efit of this procedure in adult pts of advanced age.
Methods: We performed transcatheter ASD closure with the Amplatzer Septal Occluder
in 144 adults (mean age 51±17 yrs, range 17 to 82 yrs; 103 female). 39 pts were younger
than 40 yrs (group A), 57 were 40 to 60 yrs old (group B) and 48 were older than 60 yrs
(group C). Pts were followed for up to 5 years (mean FU 1.6±1.1 yrs).
Results: Successful ASD closure was achieved in all pts (occluder size 24 ± 5 mm, range
9 - 38mm). No major complications occurred. Minor complications were self-limited SVT
(4), transient AV-block (1) and transient ST-elevation (2). At follow-up, a mild residual left-
to-right shunt (Qp:Qs < 1.3) was found in 5 pts. Atrial fibrillation with conversion to SR
was observed in 9 pts. Prior to ASD closure, older patients had slightly but significantly
larger right ventricles (RV). Mean diameters (4-Ch view) were 41±6, 42±7 and 45±7mm
in group A, B and C, respectively. Pulmonary artery pressures (PAP) also increased with
age, and were 33±7, 38±10 and 53±17 mmHg in group A, B and C, respectively; p<
0.001). Three months after ASD closure a similar significant (p < 0.0001) decrease in RV
diameter was observed in all age groups with 8±6, 9±6 and 8±5 mm. PAP also
decreased significantly (p < 0.0001) in all three groups with the greatest change in the
oldest age group: 6±8, 7±9, and 11±14 mmHg in group A,B and C, respectively. The
most decrease of RV size and PAP occurred already on the first day after the interven-
tion.
Of the 81 pts who were symptomatic prior to intervention, 30 were in group B and 40 in
group C. 32 patients were markedly symptomatic (NYHA class >II) of whom 25 were in
group C. All but two pts improved. These two pts, who remained in NYHA class III, had
persistent pulmonary hypertension and severe COPD, respectively. All other pts were
asymptomatic or had only mild exertional dyspnea at FU.
Conclusion: Regression of RV size and PAP after transcatheter ASD closure can gener-
ally be expected even in patients of advanced age. These patients also show marked
symptomatic improvement.
1019-206 Reduced Adverse Event Rates After Transcatheter 
Closure of Patent Foramen Ovale When Using the 
Amplatzer-PFOTM Compared to the CardioSealTM 
Device
Sherman G. Sorensen, Peter J. Casterella, Joseph B. Muhlestein, Robert R. Pearson, 
Benjamin D. Horne, Laurie Raleigh, Jeffrey L. Anderson, Donald L. Lappe', LDS Hospital, 
Salt Lake City, UT
Background: Transcatheter closure of patent foramen ovale (PFO-C) is a low risk, out-
patient procedure for stroke prevention. Although very low death or non-fatal stroke
(CVA) rates occur after PFO-C, a variety of other neurologic sequelal (ONS) and device-
related complications (DRC) (ie thrombus, late device deformation requiring removal, or
endocarditis) do occur and may increase post-procedural testing and cost. The two avail-
able PFO-C devices, Amplatzer-PFOTM (AMP) and CardioSealTM (CS) devices differ sig-
nificantly in design, materials and deformability, but whether these differences effect post-
procedural outcome after PFO-C is unknown.
Methods: A total of 370 consecutive patients undergoing PFO-C at a single institution
between January, 2001 and May, 2003 were followed for occurrence of death, CVA, ONS
(requiring evaluation by either brain imaging or trans-esophageal echo), or DRC. Of
these, 261 (71%) (age = 50±15 yrs, males = 42%, follow-up (F/U) = 17±7 months)
received CS and 109 (29%) (age = 49±15 yrs, males = 33%, F/U = 6±2 months) received
AMP. Patients recieving CS or AMP were compared by cox hazard analysis adjusted for
baseline variables and length of follow-up.
Results: Incidence of death (3, 0.8%) and CVA (2, 0.5%) was low and did not differ
between groups. Incidence of DRC was 8 (2.2%), only occurred in the CS device and
generally occurred late (median = 11 months) during follow-up. Incidence of ONS was
significantly greater [78 (30%) versus 7 (6.4%), p<0.001] in patients receiving CS than
AMP. The Cox hazard of ONS was significantly greater for CS versus AMP [univariate
hazard ratio (HR) = 0.26 (CI=0.11-0.63, p=0.002), adjusted HR = 0.25 (CI=0.11-0.59,
p=0.001)] as well as for any adverse event [univariate HR = 0.30 (CI=0.14-0.67,
p=0.003), adjusted HR = 0.25 (CI=0.14-0.67, p=0.003)].
Conclusion: In this large single-center consecutive study of patients undergoing PFO-C,
adverse event rates were significantly reduced by the use of the Amplatzer-PFOTM com-
pared with the CardioSealTM device. The underlying reasons for these results require fur-
ther study.
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1039-199 Reduction of QRS Duration After Pulmonary Valve 
Replacement in Adult Fallot Patients Is Related to 
Degree of Reduction of Right Ventricular Volume
Bart Hooft van Huysduynen, Cees A. Swenne, Arie C. Maan, Alexander van Straten, 
Henk J. Ritsema van Eck, Martin J. Schalij, Ernst E. van der Wall, Albert de Roos, Mark 
G. Hazekamp, Hubert W. Vliegen, Leiden University Medical Center, Leiden, The 
Netherlands
Background:
Severely prolonged QRS duration in patients (pts) late after total correction of tetralogy of
Fallot (TOF) is associated with ventricular tachycardia (VT) and sudden death. Stabiliza-
tion of QRS duration on the long run has been shown after pulmonary valve replacement
(PVR), however, the short-term effects of PVR, and the relation to degree of reduction of
RV volume is unknown. Optimal timing of PVR remains subject to debate.
Methods: 26 adult TOF pts who underwent PVR were included. Standard 12 lead ECGs
were recorded before and one year after PVR and analysed by a blinded observer. QRS
duration was determined with a computer program using averaging techniques. Cardiac
MRI was performed to assess RV dimensions.
Results: QRS duration decreased in 17 pts from 148 ± 32 to 139 ± 32 ms, remained
constant: 156 ± 10 ms in 3 pts, and increased slightly in 6 pts from 149 ± 33 to 151 ± 33
ms. For the whole group, the QRS duration shortened from 149 ± 30 to 144 ± 31ms,
p<0.001. Cardiac MRI showed a RV end-diastolic volume decrease from 305 ± 87 to 210
± 62 mL (p<0.001). QRS duration correlated well with RV end-diastolic volume (r = 0.5, p
= 0.01, see figure).
Conclusion: In adult patients with TOF, late after total repair, PVR leads to a reduction of
QRS duration in the majority of patients. The degree of reduction of QRS duration is
associated with the degree of RV reduction. Improvement of this marker for VT and sud-
den death supports a less restrictive management concerning PVR in these pts. 
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1039-200 Outcome of Patients With D-Transposition of the Great 
Arteries With Abnormal Pulmonary Valve or Left 
Ventricular Outflow Tract Obstruction Following Arterial 
Switch Operation
Mahnaz Tabibian, Jan M. Quaegebeur, Ralph S. Mosca, Jacqueline M. Lamour, Beth 
Feller Printz, New York Presbyterian Hospital, Columbia University College of Physicians 
and Surgeons, New York, NY
Background: There have been few reports regarding the long-term outcome of the arte-
rial switch operation (ASO) in patients (pts) with transposition of the great arteries (TGA)
and abnormalities of the left ventricular outflow tract (LVOT).
Methods: Records of all pts who underwent primary ASO from 1/90 to 2/02 were retro-
spectively reviewed. Pre-operative echocardiograms and operative notes identified 30 pts
with either LVOT obstruction (n=6) or an abnormal pulmonary valve (n=24). Abnormali-
ties included bicuspid pulmonary valve (n=15), thickened or doming pulmonary valve
(n=8), subpulmonary obstruction (subPS) (n=6), or combination (n=1). Pre-operative
LVOT continuous wave Doppler gradients ranged from 15-44 mmHg. Blinded review was
performed on the latest follow-up echocardiogram to evaluate the LVOT and neo-aortic
valve.
Results: Median age at operation was 7 days (range 1 to 62) and mean follow-up was 5.2
years (range 0.4 to 10). Surgical intervention to relieve subPS was performed in 2 pts
during ASO. Two pts died, one from sepsis and one from biventricular failure due to
native coronary stenosis; all others are alive. No pt has required re-intervention for LVOT
obstruction or aortic insufficiency. Follow-up echocardiograms were reviewed in 25/28
surviving pts. Mean LVOT gradient was 12 mmHg (range 0 to 17) by continuous wave
Doppler. Mean neo-aortic annulus z score was 3.2 ± 2.6 and in 19/25 pts (76%), aortic
annulus z score was >2. Mean neo-aortic root z score at the level of the sinus of Valsalva
was 3.8 ± 2.3 and neo-aortic root z score was >2 in 22/25 pts (88%). Color flow Doppler
demonstrated <= mild neo-aortic insufficiency (AI) in 23/25 pts. Moderate AI was present
in 2/25 pts (8%) who had neo-aortic root z scores of 3.9 and 7.6. In pts with no evidence
of LVOT who underwent ASO at our institution, 4 of 230 pts (2%) had moderate or severe
AI at latest follow-up.
Conclusion: ASO can be performed successfully in pts with abnormal pulmonary valve or
LVOT obstruction, with long-term results similar to pts without LVOT abnormalities. The
degree of neo-aortic root dilatation and insufficiency warrants further review.
1039-201 Mode and Site of Induction Affects the Organization of 
Atrial Fibrillation in the Canine Atrium
Joseph Ulphani, Britta Windhagen-Mahnert, Rahul Aggarwal, David Johnson, Darlene 
Racker, David Gordon, Taresh Taneja, Jeffrey Goldberger, Alan Kadish, Northwestern 
University, Chicago, IL
Background: The purpose of this study was to test the hypothesis that both the mode
and site of induction of atrial fibrillation (AF) can alter its resultant organization.
Methods: Episodes of AF were induced in 18 normal mongrel dogs using both atrial pac-
ing and aconitine administration. The site of AF induction was the right atrium (RA) and
left atrium (LA) in 9 dogs each. Using plaque electrodes (2.5-mm inter-electrode dis-
tance), 112 electrograms were recorded from each atrium. Activation was evaluated dur-
ing AF using both the local atrial cycle length (CL) and a frequency corrected ensemble
vector index (EVI). The EVI is an integrated vector loop that is large when activation
direction is consistent and low when activation direction is variable. Mean local atrial CL
and the EVI were analyzed and compared for mode and site of AF induction.
Results: The frequency corrected EVI during aconitine induced AF (10.7+8.4) was sig-
nificantly (p<0.0001) higher than pacing induced AF (9.1+5.9). The mean local atrial CL
(milleseconds) was lower during pacing induced AF than during aconitine induced AF
(114.5+40.6 vs 114.8+50.9, p=.03). The EVI was greater for AF induced from the RA
than from the LA (10.9±7.3 vs 8.9±7.1, p<0.0001). In contrast, the CL was longer for AF
induced from the LA than from the RA (119.3±42.5 vs 111.0±47.9, p<0.001).
Conclusion: There is a higher beat-to-beat consistency during aconitine-induced AF
than during pacing-induced AF. Furthermore, there appears to be more consistency
when AF is induced from the RA than from the LA. These findings may explain the pro-
pensity for LA (or pulmonary vein) tachycardias to induce AF.
1039-202 Pulmonary Valve Replacement in Childhood: Does Early 
Treatment of Pulmonary Insufficiency Improve 
Outcome?
Anji T. Yetman, Brian K. Eble, Carl W. Chipman, Jonathan J. Drummond-Webb, 
University of Colorado Health Sciences Center, Denver, CO, University of Arkansas for 
Medical Sciences, Little Rock, AR
Background: The detrimental effect of chronic pulmonary insufficiency (PI) following
repair of tetralogy of Fallot (ToF) on right ventricular (RV) performance has been well-
established. While pulmonary valve replacement (PVR) is performed routinely in adult
patients with chronic PI, exercise performance may remain impaired secondary to irre-
versible RV dysfunction. There is no data assessing the frequency or outcome of children
(age < 18 years) undergoing PVR for isolated PI following ToF repair. Methodology: Ret-
rospective data review of all children undergoing PVR at a single institution for symptom-
atic isolated PI following previous ToF repair was performed. Results: During the 10 year
period 1993-2003, 48 PVR were performed in 46 children for PI with associated symp-
tomatic RV dilation at a mean age of 12.9 + 3.9 years and weight of 42.4 + 19.7 kg yield-
ing a frequency of childhood PVR following ToF repair of 44% (46/105 patients
undergoing ToF repair between 4/82-5/96). The interval from initial ToF repair to PVR
was 10.6 + 3.9 years. Type of PVR included pulmonary homograft in 10, Hancock porcine
bioprosthesis in 12, Edwards bovine pericardial bioprosthesis in 16, and porcine valved
conduit in 4. Median valve size was 25 (17-29). Patients were followed for a period of up
to 10 years post PVR (3.6 + 2.5 years). Re-operation was required in 2 patients: 1 patient
with endocarditis of the PV 2 years post implant and the other with severe PI 8 years post
PVR. There were no surgery related deaths. On follow-up, 3 additional patients had >
mild PI, and 5 > mild PS. RV size fell from 34.5 mm prior to PVR to 23.8 mm post PVR
(p<.001). Exercise testing pre- PVR in 24 children revealed a peak VO2 of 27.3 ml/kg/min
(60% predicted). Follow-up stress testing revealed an improved aerobic capacity with a
peak VO2 34.3 ml/kg/min (73% predicted) [p=.02]. Conclusion: Children undergoing
repair of ToF in infancy are frequently left with symptomatic PI. Early PVR is associated
with improved echocardiographic RV appearance and improved functional capacity. The
risk of repeat surgical intervention needs to be weighed against the benefit of preserva-
tion of right ventricular function.
1039-203 Aortopulmonary Window: Late Results of Surgical 
Repair in 40 Patients
Harold M. Burkhart, David A. Ashburn, Julia Ritter, John Coles, Gary Webb, Glen S. Van 
Arsdel, William G. Williams, Toronto Hospital for Sick Children, Toronto, ON, Canada, 
University of Iowa, Iowa City, IA
Background:This study was undertaken to determine the long-term outcomes of
patients undergoing aortopulmonary window (APW) repair.
Methods: Between January 1971 and January 2003, surgical repair of APW was per-
formed on 40 patients (20 males, 20 females). Median age was 3.3 months (range, 2
days to 10 years). Thirty patients (75%) had Type I defect (window between the aortic
and pulmonary trunks), nine (23%) had Type II (defect extending to the origin of the right
main pulmonary artery (RMPA)), and one (2%) had Type III (RMPA from ascending
aorta). Twenty-three patients (58%) had additional cardiac defects including atrial septal
defect (n=6), ventricular septal defect (n=5), interrupted aortic arch (n=4), aortic coarcta-
tion (n=4), right aortic arch (n=3), and tetralogy of Fallot (n=2). Mean preoperative sys-
temic arterial oxygen saturations (SAO2) were 93 ± 10%.
Results: Thirty-seven patients had patch (n=36) or suture closure (n=1) of the defect via
an incision in the window (n=18, 49%), pulmonary artery (n=13, 35%), or aorta (n=6,
16%). Three patients underwent simple ligation of the defect. There was one early death
(2.5%). Follow-up was complete in 98%. Median follow-up was 8 years (range 6 months
to 30 years). Actuarial survival is 98%, 94%, and 86% at 5, 15, and 25 years, respec-
tively. Freedom from surgical or catheter reintervention is 85%, 76%, and 51% at 5, 15,
and 25 years, respectively. Risk factors for death or reintervention include APW Type II
(P=0.08) and lower preoperative SAO2 (P=0.004). The majority (95%) of present survi-
vors are NYHA class I (n=32) or II (n=5) at follow-up.
Conclusions: Surgical repair of APW can be performed with low early and late mortality.
Early repair of APW and associated anomalies is advocated. The majority of late survi-
vors have a good quality of life.
1039-204 Rapidly Detective Value of Heart Fatty Acid-Binding 
Protein at Risk for Myocardial Damage in Pediatric 
Cardiac Operation
Tomomi Hasegawa, Masahiro Yamaguchi, Naoki Yoshimura, Shigeteru Oka, Yoshio 
Ootaki, Yutaka Okita, Kobe University Graduate School of Medicine, Kobe, Japan, Kobe 
Children's Hospital, Kobe, Japan
Objective: Heart fatty acid-binding protein (HFABP) is reported as a rapid marker of
myocardial damage in adults. The objective of this study was to assess the suitability of
using serum levels of HFABP for evaluation of myocardial damage in pediatric cardiac
surgery.
Method: One hundred patients in pediatric cardiac surgery were prospectively enrolled.
Mean age at operation was 4.9 ± 0.4 years. Serum levels of HFABP, creatin kinase isoen-
zyme MB (CK-MB) and troponin T (TnT) were measured serially before operation and 0,
1, 2, 3 and 6 hours after an aortic declamping.
Result: Serum HFABP reached to peak level at 1 hour after declamping in 95 patients,
which was significantly earlier than serum CK-MB or TnT (Fig 1). In addition, serum
HFABP levels immediately after declamping correlated strongly with serum peak HFABP
levels (Fig 2). The serum peak level of HFABP correlated with those of CK-MB and TnT
(p< 0.01 for each). In the multiple regression analysis, age and aortic cross-clamp time
were significant variables that influenced the release of HFABP (p<0.0001 for each).
There were good relationship between serum peak HFABP levels and postoperative ino-
